{"log_id": 6266252461546600412, "direction": 0, "words_result_num": 44, "words_result": [{"probability": {"variance": 0.000318, "average": 0.978743, "min": 0.949478}, "location": {"width": 153, "top": 153, "height": 36, "left": 82}, "words": "【药物过量】"}, {"probability": {"variance": 0.019507, "average": 0.915551, "min": 0.39755}, "location": {"width": 1243, "top": 210, "height": 52, "left": 146}, "words": "在动物实验中,依维莫可发生急海性的口能性低。在单次口服200mg/kg剂量水平的小鼠和大鼠中均"}, {"probability": {"variance": 0.004075, "average": 0.958507, "min": 0.789935}, "location": {"width": 512, "top": 265, "height": 36, "left": 91}, "words": "没有观察到致死性或严重毒性(有限试验"}, {"probability": {"variance": 0.030023, "average": 0.88964, "min": 0.454295}, "location": {"width": 1245, "top": 315, "height": 57, "left": 141}, "words": "报告的人体药物过经验非常有限。单次用药剂量曾高达70mg其急性耐受性可接受。在70mg剂量水"}, {"probability": {"variance": 0.002095, "average": 0.971427, "min": 0.788202}, "location": {"width": 612, "top": 370, "height": 48, "left": 89}, "words": "平所观察到的急性毒性特点与10mg剂量水1一致"}, {"probability": {"variance": 0.020073, "average": 0.944642, "min": 0.394347}, "location": {"width": 521, "top": 429, "height": 36, "left": 144}, "words": "在药物过情况下,均应使用全身支持疗法"}, {"probability": {"variance": 7.7e-05, "average": 0.993421, "min": 0.974474}, "location": {"width": 150, "top": 528, "height": 36, "left": 80}, "words": "【临床试验】"}, {"probability": {"variance": 0.000186, "average": 0.982873, "min": 0.964674}, "location": {"width": 166, "top": 585, "height": 34, "left": 86}, "words": "晚期肾细胞癌"}, {"probability": {"variance": 0.000964, "average": 0.985773, "min": 0.90387}, "location": {"width": 224, "top": 640, "height": 36, "left": 139}, "words": "国外临床研究结果"}, {"probability": {"variance": 0.015428, "average": 0.944052, "min": 0.449269}, "location": {"width": 1213, "top": 694, "height": 50, "left": 169}, "words": "项国际多中心、随机、双盲试验,在往使用舒尼替尼、紫拉非尼或序使用这二种药物治疗并出现"}, {"probability": {"variance": 0.017745, "average": 0.925753, "min": 0.452453}, "location": {"width": 1291, "top": 747, "height": 52, "left": 86}, "words": "疾病进展的转移性肾细胞癌思者中,比较本品10mg每日一次训最佳支持治疗和安您剂加最佳支持治疗。也"}, {"probability": {"variance": 0.012713, "average": 0.93633, "min": 0.608186}, "location": {"width": 1238, "top": 802, "height": 52, "left": 84}, "words": "允许既往使用贝伐单抗、白细胞介素2或a干扰素治疗。按照预后评分和往抗肿治疗进行机分层"}, {"probability": {"variance": 0.033758, "average": 0.890145, "min": 0.365479}, "location": {"width": 1204, "top": 859, "height": 50, "left": 146}, "words": "安实体瘤疗效评价标准( RECIST1.0版),山盲态、独立中心射学审核评无进展生存(PTS)"}, {"probability": {"variance": 0.006532, "average": 0.951303, "min": 0.643769}, "location": {"width": 1293, "top": 912, "height": 52, "left": 84}, "words": "在放学检查记录到疾病进展后,研究者可进行患者揭育:随机到安慰剂的患者可开放性使用品10mg每"}, {"probability": {"variance": 0.017939, "average": 0.884788, "min": 0.660973}, "location": {"width": 132, "top": 971, "height": 32, "left": 86}, "words": "日一次治疗"}, {"probability": {"variance": 0.020057, "average": 0.895898, "min": 0.395112}, "location": {"width": 1243, "top": 1026, "height": 41, "left": 132}, "words": "总计416名患者按照2:1比例,随机使用本品(n277)或安慰剂(n=1.39个治疗组之间人门统计"}, {"probability": {"variance": 0.035213, "average": 0.896699, "min": 0.354102}, "location": {"width": 1293, "top": 1078, "height": 50, "left": 82}, "words": "学平衡良好(中位年龄61岁:77为男性:8%为高加索人:74%既注用尼替尼或索拉非足,25%厂费"}, {"probability": {"variance": 0.01264, "average": 0.944228, "min": 0.672504}, "location": {"width": 189, "top": 1136, "height": 32, "left": 82}, "words": "使用这二种药物"}, {"probability": {"variance": 0.025454, "average": 0.915766, "min": 0.388696}, "location": {"width": 1243, "top": 1188, "height": 48, "left": 130}, "words": "使用本品的PS优于安慰剂组(参见表8图1)。在预后浮分和既往使用拉非尼和或舒替尼的"}, {"probability": {"variance": 0.024794, "average": 0.906176, "min": 0.401414}, "location": {"width": 1293, "top": 1241, "height": 52, "left": 77}, "words": "分层之间,治疗效果相似,最终总生存期(OS)结果得出的风比为0.90(95%Cl:0.71-1.14),两个治疗"}, {"probability": {"variance": 0.02679, "average": 0.900687, "min": 0.394753}, "location": {"width": 1298, "top": 1296, "height": 54, "left": 75}, "words": "红之间未见统计学显著差异,这是由于根据方案因疾进展面从安慰剂汇转至于的本品组的患者占799%"}, {"probability": {"variance": 0.020454, "average": 0.889732, "min": 0.501468}, "location": {"width": 505, "top": 1355, "height": 36, "left": 96}, "words": "139),这可能影响了OS获益的评估"}, {"probability": {"variance": 0.00376, "average": 0.975452, "min": 0.74087}, "location": {"width": 438, "top": 1410, "height": 34, "left": 73}, "words": "表8:中心放射学评估的有效性结果"}, {"probability": {"variance": 0.025698, "average": 0.892092, "min": 0.576317}, "location": {"width": 141, "top": 1483, "height": 34, "left": 550}, "words": "依维莫可片"}, {"probability": {"variance": 0.051608, "average": 0.825864, "min": 0.504965}, "location": {"width": 89, "top": 1483, "height": 34, "left": 802}, "words": "安慰剂"}, {"probability": {"variance": 0.000225, "average": 0.987454, "min": 0.966269}, "location": {"width": 91, "top": 1483, "height": 34, "left": 1021}, "words": "风险比"}, {"probability": {"variance": 6.5e-05, "average": 0.990239, "min": 0.978653}, "location": {"width": 77, "top": 1529, "height": 25, "left": 582}, "words": "N=277"}, {"probability": {"variance": 0.013569, "average": 0.933912, "min": 0.701606}, "location": {"width": 77, "top": 1531, "height": 25, "left": 804}, "words": "N=139"}, {"probability": {"variance": 0.041946, "average": 0.741875, "min": 0.537068}, "location": {"width": 52, "top": 1510, "height": 32, "left": 1243}, "words": "p位"}, {"probability": {"variance": 0.092611, "average": 0.741637, "min": 0.314374}, "location": {"width": 123, "top": 1531, "height": 27, "left": 1008}, "words": " (9S G0 CD"}, {"probability": {"variance": 4.6e-05, "average": 0.991886, "min": 0.979497}, "location": {"width": 226, "top": 1574, "height": 34, "left": 86}, "words": "中位无进展生存期"}, {"probability": {"variance": 0.039266, "average": 0.877689, "min": 0.534878}, "location": {"width": 84, "top": 1579, "height": 32, "left": 580}, "words": "19个月"}, {"probability": {"variance": 1e-06, "average": 0.99784, "min": 0.996965}, "location": {"width": 89, "top": 1581, "height": 32, "left": 800}, "words": "19个月"}, {"probability": {"variance": 0.000463, "average": 0.983689, "min": 0.946723}, "location": {"width": 50, "top": 1586, "height": 27, "left": 1040}, "words": "0.33"}, {"probability": {"variance": 0.010145, "average": 0.949839, "min": 0.703551}, "location": {"width": 84, "top": 1588, "height": 27, "left": 1234}, "words": "c0.0001"}, {"probability": {"variance": 0.028169, "average": 0.884312, "min": 0.551849}, "location": {"width": 109, "top": 1629, "height": 29, "left": 114}, "words": "95%CT"}, {"probability": {"variance": 0.003983, "average": 0.967236, "min": 0.802359}, "location": {"width": 102, "top": 1634, "height": 27, "left": 573}, "words": "4.0-5.5)"}, {"probability": {"variance": 0.00318, "average": 0.951927, "min": 0.827869}, "location": {"width": 98, "top": 1634, "height": 29, "left": 790}, "words": "(1.8-1.9"}, {"probability": {"variance": 0.00384, "average": 0.967245, "min": 0.785717}, "location": {"width": 132, "top": 1638, "height": 29, "left": 1001}, "words": "0.25-0.43)"}, {"probability": {"variance": 0.024339, "average": 0.89773, "min": 0.589561}, "location": {"width": 141, "top": 1680, "height": 32, "left": 84}, "words": "客观缓解率"}, {"probability": {"variance": 1.5e-05, "average": 0.996099, "min": 0.992203}, "location": {"width": 34, "top": 1687, "height": 32, "left": 598}, "words": "2%"}, {"probability": {"variance": 0, "average": 0.996537, "min": 0.996537}, "location": {"width": 25, "top": 1689, "height": 27, "left": 829}, "words": "%"}, {"probability": {"variance": 0.022818, "average": 0.899249, "min": 0.474438}, "location": {"width": 448, "top": 1732, "height": 43, "left": 91}, "words": "按照预后评分分层,进行对数轶检验"}, {"probability": {"variance": 4e-06, "average": 0.995519, "min": 0.993475}, "location": {"width": 84, "top": 1780, "height": 32, "left": 93}, "words": "不适用"}], "language": 3}